Literature DB >> 1908222

Homodimer and heterodimer subunits of human prostate acid phosphatase.

H Lee1, T M Chu, S S Li, C L Lee.   

Abstract

Human prostatic acid phosphatase (PAP) isoenzymes, designated PAP-A and PAP-B, were isolated from human seminal plasma by sequential affinity chromatography on concanavalin A and L(+)-tartrate, a classic inhibitor of PAP. Both the major PAP-A and the minor PAP-B isoenzymes exhibited a similar molecular mass (100 and 105 kDa respectively), multiple pI values (5.05-5.35 and 5.05-5.12), and substrate and inhibitor specificity. Immunological characterization revealed that PAP-B possesses distinct antigenic determinants, in addition to the common sites shared with PAP-A. SDS/PAGE indicated that both isoenzymes are composed of two subunits of 50 kDa each. At high salt concentration, PAP-B dissociated completely into single subunits of 50 kDa, whereas PAP-A remained intact at 100 kDa. PAP-B was resolved by reverse-phase h.p.l.c. into three components, designated alpha, beta and gamma, each of 50 kDa, at a molar ratio of approx. 2:1:1. PAP-A contained a single component of molecular mass 50 kDa. The single component of PAP-A and the alpha component of PAP-B possessed identical amino acid compositions and N-terminal sequences, which were different from those of the beta and gamma components. These results indicate that human PAP contains three isoforms, alpha 2, alpha beta and alpha gamma. PAP-A, the major isoenzyme, is a homodimer consisting of two identical subunits (alpha 2), and PAP-B, the minor isoenzyme, is a mixture of two heterodimers, consisting of non-identical subunits (alpha beta and alpha gamma).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1908222      PMCID: PMC1151309          DOI: 10.1042/bj2770759

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

1.  AN " ACID " PHOSPHATASE OCCURRING IN THE SERUM OF PATIENTS WITH METASTASIZING CARCINOMA OF THE PROSTATE GLAND.

Authors:  A B Gutman; E B Gutman
Journal:  J Clin Invest       Date:  1938-07       Impact factor: 14.808

Review 2.  Phosphotyrosyl protein phosphatases.

Authors:  K H Lau; J R Farley; D J Baylink
Journal:  Biochem J       Date:  1989-01-01       Impact factor: 3.857

3.  Purification and properties of polycation-stimulated phosphorylase phosphatases from rabbit skeletal muscle.

Authors:  E Waelkens; J Goris; W Merlevede
Journal:  J Biol Chem       Date:  1987-01-25       Impact factor: 5.157

4.  Molecular cloning of cDNA for human prostatic acid phosphatase.

Authors:  L C Yeh; A J Lee; N E Lee; K W Lam; J C Lee
Journal:  Gene       Date:  1987       Impact factor: 3.688

5.  Human prostatic acid phosphatase: cDNA cloning, gene mapping and protein sequence homology with lysosomal acid phosphatase.

Authors:  F S Sharief; H Lee; M M Leuderman; A Lundwall; L L Deaven; C L Lee; S S Li
Journal:  Biochem Biophys Res Commun       Date:  1989-04-14       Impact factor: 3.575

6.  An improved acid phosphatase procedure.

Authors:  A L Babson; G E Phillips
Journal:  Clin Chim Acta       Date:  1966-02       Impact factor: 3.786

7.  Human prostatic acid phosphatase has phosphotyrosyl protein phosphatase activity.

Authors:  M F Lin; G M Clinton
Journal:  Biochem J       Date:  1986-04-15       Impact factor: 3.857

Review 8.  The structure and regulation of protein phosphatases.

Authors:  P Cohen
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

9.  Three distinct forms of type 2A protein phosphatase in human erythrocyte cytosol.

Authors:  H Usui; M Imazu; K Maeta; H Tsukamoto; K Azuma; M Takeda
Journal:  J Biol Chem       Date:  1988-03-15       Impact factor: 5.157

10.  Human liver phosphatase 2A: cDNA and amino acid sequence of two catalytic subunit isotypes.

Authors:  J Arino; C W Woon; D L Brautigan; T B Miller; G L Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

View more
  6 in total

1.  Tumor biomarker glycoproteins in the seminal plasma of healthy human males are endogenous ligands for DC-SIGN.

Authors:  Gary F Clark; Paola Grassi; Poh-Choo Pang; Maria Panico; David Lafrenz; Erma Z Drobnis; Michael R Baldwin; Howard R Morris; Stuart M Haslam; Sophia Schedin-Weiss; Wei Sun; Anne Dell
Journal:  Mol Cell Proteomics       Date:  2011-10-10       Impact factor: 5.911

2.  Structure of Thermotoga maritima stationary phase survival protein SurE: a novel acid phosphatase.

Authors:  R G Zhang; T Skarina; J E Katz; S Beasley; A Khachatryan; S Vyas; C H Arrowsmith; S Clarke; A Edwards; A Joachimiak; A Savchenko
Journal:  Structure       Date:  2001-11       Impact factor: 5.006

3.  Glycoconjugates with Neu5Ac(alpha 2,6)Gal(beta 1,4)GlcNAc sequences: a selective lectin-histochemical property of Kurloff cells in guinea pig thymus.

Authors:  N Oulhaj; S E Letaïef; G Landemore; J Izard
Journal:  Cell Tissue Res       Date:  1993-01       Impact factor: 5.249

Review 4.  Human prostatic acid phosphatase: structure, function and regulation.

Authors:  Sakthivel Muniyan; Nagendra K Chaturvedi; Jennifer G Dwyer; Chad A Lagrange; William G Chaney; Ming-Fong Lin
Journal:  Int J Mol Sci       Date:  2013-05-21       Impact factor: 5.923

5.  Secretion and N-linked glycosylation are required for prostatic acid phosphatase catalytic and antinociceptive activity.

Authors:  Julie K Hurt; Brendan J Fitzpatrick; Jacqueline Norris-Drouin; Mark J Zylka
Journal:  PLoS One       Date:  2012-02-28       Impact factor: 3.240

Review 6.  Emerging roles of human prostatic Acid phosphatase.

Authors:  Hoon Young Kong; Jonghoe Byun
Journal:  Biomol Ther (Seoul)       Date:  2013-01       Impact factor: 4.634

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.